DK1071439T3 - Hybenformuleringer som antiinflammatorisk naturmedicin til lindring/reduktion af symptomer associeret med inflammation og artritis - Google Patents

Hybenformuleringer som antiinflammatorisk naturmedicin til lindring/reduktion af symptomer associeret med inflammation og artritis

Info

Publication number
DK1071439T3
DK1071439T3 DK99913122T DK99913122T DK1071439T3 DK 1071439 T3 DK1071439 T3 DK 1071439T3 DK 99913122 T DK99913122 T DK 99913122T DK 99913122 T DK99913122 T DK 99913122T DK 1071439 T3 DK1071439 T3 DK 1071439T3
Authority
DK
Denmark
Prior art keywords
arthritis
inflammation
symptoms associated
chemotaxis
relief
Prior art date
Application number
DK99913122T
Other languages
English (en)
Inventor
Arsalan Kharazmi
Eydbjoerg Rein
Kaj Winther
Original Assignee
Hansen Otto Torbjoern
Hansen Marianne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hansen Otto Torbjoern, Hansen Marianne filed Critical Hansen Otto Torbjoern
Application granted granted Critical
Publication of DK1071439T3 publication Critical patent/DK1071439T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738—Rosa (rose)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK99913122T 1998-04-17 1999-04-16 Hybenformuleringer som antiinflammatorisk naturmedicin til lindring/reduktion af symptomer associeret med inflammation og artritis DK1071439T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/061,969 US6024960A (en) 1998-04-17 1998-04-17 Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis

Publications (1)

Publication Number Publication Date
DK1071439T3 true DK1071439T3 (da) 2006-10-16

Family

ID=22039366

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99913122T DK1071439T3 (da) 1998-04-17 1999-04-16 Hybenformuleringer som antiinflammatorisk naturmedicin til lindring/reduktion af symptomer associeret med inflammation og artritis

Country Status (12)

Country Link
US (1) US6024960A (da)
EP (1) EP1071439B1 (da)
JP (1) JP4514333B2 (da)
AT (1) ATE329605T1 (da)
AU (1) AU759394B2 (da)
CY (1) CY1105188T1 (da)
DE (1) DE69931907T2 (da)
DK (1) DK1071439T3 (da)
ES (1) ES2267259T3 (da)
NZ (1) NZ501790A (da)
PT (1) PT1071439E (da)
WO (1) WO1999053934A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787320B1 (fr) * 1998-12-17 2002-11-29 Veronique Simon Nouvelle methode de peeling et preparations pour la mise en oeuvre de cette methode
US6524609B1 (en) * 1999-08-18 2003-02-25 Nutri-Vet, Llc Treating arthritis in animals with dietary supplements
US6485752B1 (en) 2000-10-23 2002-11-26 Otto Torbjorn Hansen Composition and method for alleviating joint pain and stiffness
US6979470B2 (en) * 2001-07-17 2005-12-27 Metaproteomics, Llc Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
JP2005501094A (ja) * 2001-08-21 2005-01-13 ガリレオ ファーマシューティカルズ， インコーポレイティド トコフェロール富化組成物および炎症性症状の回復
AU2002366210A1 (en) * 2001-11-21 2003-06-10 Danmarks Farmaceutiske Hojskole Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents
US20030170327A1 (en) * 2002-03-05 2003-09-11 Dahl Eva Marie Vitamin and zinc monomethionine compositions
US20070003600A1 (en) * 2003-06-11 2007-01-04 Carolyn Moore Methods for reducing c-reactive protein
US7758902B2 (en) * 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US7838050B2 (en) * 2003-09-12 2010-11-23 Access Business Group International Llc Cytokine modulators and related method of use
US7758903B2 (en) 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
JP2006316026A (ja) * 2005-05-16 2006-11-24 American Biologics Japan Kk バラ科植物抽出物等およびそれらを利用した免疫細胞活性化剤
CN101291681A (zh) * 2005-08-23 2008-10-22 捷通国际有限公司 细胞因子调节物及相关使用方法
WO2007113007A2 (en) * 2006-04-04 2007-10-11 Dsm Ip Assets B.V. Package containing a polyphenol and their uses
WO2008006589A2 (en) 2006-07-14 2008-01-17 Dsm Ip Assets B.V. Compositions comprising rosehip and other active agents for the treatment of inflammatory disorders
WO2008006582A1 (en) * 2006-07-14 2008-01-17 Dsm Ip Assets B.V. Compositions comprising magnolol or honokiol and other active agents for the treatment of inflammatory diseases
UA102678C2 (ru) * 2007-12-21 2013-08-12 Финцельберг Гмбх Унд Ко. Кг Композиция с экстрактом из плодов шиповника и способ получения экстракта из плодов шиповника
US20110262612A1 (en) * 2008-04-17 2011-10-27 Goetz Nicolle Rosehip powder having small particle size
NZ567712A (en) * 2008-04-24 2010-11-26 Fonterra Cooperative Group Ltd Compositions and methods for maintaining bone health or reducing bone loss
US9173912B2 (en) * 2008-05-06 2015-11-03 Finzelberg Gmbh & Co. Kg Cistus extract containing enriched secondary plant ingredients
WO2010048955A1 (en) 2008-10-30 2010-05-06 Hyben Vital Licens Aps Composition comprising a glycoside of a mono- or diacyiglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition
DE102009030351A1 (de) 2009-06-22 2010-12-23 Gelita Ag Zusammensetzung zur Behandlung von degenerativen Gelenkerkrankungen
DK177605B1 (en) 2010-03-16 2013-11-18 Hyben Vital Licens Aps Compositions of rose hips enriched with seeds of rose hips and their use as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and joint diseases such as arthritis and/or osteo-arthritis
EP2872135B1 (en) 2012-07-06 2016-10-26 Orkla Health A/S Process for the manufacture of rose hip powder
JP6368229B2 (ja) * 2014-12-02 2018-08-01 幸三 飯島 ビタミンｃ飲料の製造方法
WO2016173995A1 (en) 2015-04-28 2016-11-03 Hyben Vital Licens Aps Rose hip product comprising rose hip seeds
US20190292226A1 (en) * 2018-03-23 2019-09-26 Arch Biosurgery, Inc. Sap and peptidomimetic compositions for reducing symptoms of inflammation
KR102125628B1 (ko) * 2018-12-11 2020-06-23 주식회사 엘리바이오 로즈힙을 함유하는 연골손상방지 내지 재생용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521275A1 (fr) * 1982-02-08 1983-08-12 Creusot Loire Echangeur thermique a faisceau tubulaire metallique pour hautes temperatures
US4774229A (en) * 1982-04-05 1988-09-27 Chemex Pharmaceuticals, Inc. Modification of plant extracts from zygophyllaceae and pharmaceutical use therefor
JPH0441436A (ja) * 1990-06-04 1992-02-12 Sodetsukusu Kk 抗酸化性組成物
RU2045917C1 (ru) * 1993-07-13 1995-10-20 Всероссийский научно-исследовательский институт консервной и овощесушильной промышленности Способ переработки ягод шиповника и линия для его осуществления
JPH07138151A (ja) * 1993-11-15 1995-05-30 Kanebo Ltd ソフトカプセル剤及びその製造方法
US5744187A (en) * 1996-12-16 1998-04-28 Gaynor; Mitchel L. Nutritional powder composition

Also Published As

Publication number Publication date
US6024960A (en) 2000-02-15
DE69931907T2 (de) 2007-02-22
ATE329605T1 (de) 2006-07-15
AU759394B2 (en) 2003-04-17
JP2002512197A (ja) 2002-04-23
JP4514333B2 (ja) 2010-07-28
WO1999053934A1 (en) 1999-10-28
AU3138099A (en) 1999-11-08
ES2267259T3 (es) 2007-03-01
NZ501790A (en) 2001-10-26
EP1071439B1 (en) 2006-06-14
DE69931907D1 (de) 2006-07-27
PT1071439E (pt) 2006-10-31
CY1105188T1 (el) 2010-03-03
EP1071439A1 (en) 2001-01-31

Similar Documents

Publication Publication Date Title
DK1071439T3 (da) Hybenformuleringer som antiinflammatorisk naturmedicin til lindring/reduktion af symptomer associeret med inflammation og artritis
AR052921A1 (es) Uso de ranolazina para la preparacion de una composicion farmaceutica y composicion farmaceutica
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
DK1079806T3 (da) Præparater til påföringen af antiinflammatoriske, især antiseptiske midler og/eller midler, der fremmer helingen af sår, til de övre luftveje og/eller öret
ATE232396T1 (de) Oxydiertes thymosin beta 4
DK0832081T3 (da) Bicykliske-aromatiske forbindelser
DE59007288D1 (de) Verwendung des Wirkstoffs Azelastin und Glycerinethern zur Bekämpfung von Psoriasis-Erkrankungen.
AU2002231889A1 (en) Halogenated composition, method for preparing same and uses thereof
NZ328874A (en) Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders
WO2001089536A3 (en) Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
BRPI0415290A (pt) uso terapêutico de variantes de quimiocina
BR0307041A (pt) Corpos de fosfolipìdio e uso dos mesmos no tratamento de doenças inflamatórias e autoimunes
HUP9700806A2 (hu) Tianeptin-nátriumsó nyújtott felszabadulását biztosító, szájon át beadható mátrix tabletta és eljárás előállítására
DK0714304T3 (da) Terapeutisk system til behandling af psoriasis
BG101126A (en) The use of muramylpeptide compounds
DE69927260D1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
NO20030988L (no) Anvendelse av en sammensetning omfattende et pollenekstrakt for behandlingav hormonrelaterte forstyrrelser
NZ515173A (en) Treatment of hypersensitivity reaction disorders
PT100155A (pt) Uso de compostos analogos da camptotecina na obtencao de um medicamento para uso no tratamento do carcinoma das celulas nao pequenas do pulmao e composicoes farmaceuticas
DE59909855D1 (de) Wirkstoff enthaltende orale oder mucosale zubereitung mit steuerbarer wirkstofffreisetzung und ihre verwendung
NO20022739D0 (no) Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)- 2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on ognevroleptika for behandling eller forhindring av psykotiskelidelser
JPS57165313A (en) Indomethacin for external use
GEP20043317B (en) Ointment for Treatment of Purulent Diseases, Festering Wounds and Burns
MC2450A1 (fr) Composition pour le traitement topique d'affections de la peau et des phanères
WO2002045723A3 (en) Inflammatory cytokine secretion inhibition with modified mammalian blood